Paper B Flashcards
Is a given claim obvious in view of…? What is the test?
A) POSITA and CGK
- POSITA
-CGK
B) Inventive concept
C) Differences between prior art and inventive concept
D) Differences constitute obvious steps or do they require inventiveness (describe alone + combinations)
E) Conclusion
(2018)
License case law?
In Canada, a valid licence can only be obtained for a CA patent if both Chloe
Green and Greenhouses Ltd. consent to the license to Rob. (Forget v. Specialty Tools of
Canada Inc (1993), 48 CPR (3d) 323 at 331 (BCSC), aff ’d (1995), 62 CPR (3d)
537(BCCA)).
(2018)
Authority of patent act related to eliminate false inventor
The Federal Court has jurisdiction to order that any entry in the records of the Patent
Office relating to the title of a patent be varied (Section 52 of the Patent Act). It will thus
be necessary to make an application at the Federal Court to remove an inventor.
(2018)
(i) List one reason why or why not each of the claims may be patentable subject matter in
Canada.
(ii) What is the appropriate Section of the Patent Act that applies to patentable subject
matter.
Mushroom X comprising novel compound Y for treating a tumor in a subject.
Claim would be rejected since mushroom X is a higher life form.
Section 2 of the Patent Act.
(2018)
(i) List one reason why or why not each of the claims may be patentable subject matter in
Canada.
(ii) What is the appropriate Section of the Patent Act that applies to patentable subject
matter.
Novel compound Y for use in treating a tumor in a subject.
Claim would be accepted since compound Y is patentable.
Section 2 of the Patent Act.
(2018)
(i) List one reason why or why not each of the claims may be patentable subject matter in
Canada.
(ii) What is the appropriate Section of the Patent Act that applies to patentable subject
matter.
A method of treating a tumor comprising administering mushroom X to a subject.
Claim would be rejected for being directed to a method of medical treatment.
Section 2 of the Patent Act.
(2018)
(i) List one reason why or why not each of the claims may be patentable subject matter in
Canada.
(ii) What is the appropriate Section of the Patent Act that applies to patentable subject
matter.
An animal feed comprising mushroom X.
Claim would be accepted since it includes a higher life form within its scope as a component of a composition or food product.
Section 2 of the Patent Act.
(2018)
(i) List one reason why or why not each of the claims may be patentable subject matter in
Canada.
(ii) What is the appropriate Section of the Patent Act that applies to patentable subject
matter.
Use of a composition comprising mushroom X and a salt for treating a tumor in a subject
Claim would be accepted since it includes a higher life form within its scope as a use.
Section 2 of the Patent Act.
(2018)
In the United States, according to 35 U.S.C. 112 “the specification….shall set forth the best
mode contemplated by the inventor of carrying out his invention.” As can be understood from
this language, U.S. patent applications have a best mode requirement that is relevant to all
technologies. Does the Canadian Patent Act impose a similar best mode requirement? Apply the
appropriate Section(s) of the Patent Act.
YES, but limited to machines. Section 27(3)(c) of the Patent Act.
(2018)
A Canadian patent application was abandoned for failure to respond to an Office Action. Your
client contacts you in a state of panic a few days before the reinstatement deadline, and tells you
that he is unable to provide you with instructions by the deadline. He nevertheless wants to keep
this application from becoming irrevocably abandoned. Can an extension of time be requested?
Apply the appropriate Section(s) of the Patent Act and/or Rules.
Yes. The time limit for reinstatement may be extended under Subsection 26(1) of the Patent
Rules provided that the request for the extension of time is made before the period for
reinstatement expires and the fee set out in item 22 of Schedule II of the Patent Rules is paid
before the period for reinstatement expires.
(2018)
Name the three-part test for sound prediction
1) Factual basis for the prediction
2) An articulable and “sound” line of reasoning
3) Sufficient disclosure
(2018)
Name the relevant case law for the test.
Apotex Inc. v. Wellcome Foundation Ltd., [2002] 4 S.C.R. 153
(2018)
You promptly report to a US Associate a Notice of Allowance you received this morning for a
Canadian patent application. She is very excited about getting the patent application allowed for
this technology in Canada. She sends you a listing of new claims that were allowed in several US
counterpart Continuation patent applications. She requests that you promptly file a divisional
application before paying the final fee for the allowed Canadian patent application.
You have a look at the claims and they are directed to subject matter that is close to the subject
matter of the allowed Canadian patent application. No unity of invention rejection was raised
during prosecution of the allowed Canadian patent application.
Based on your assessment, what would you recommend to the US Associate before filing a
divisional application with these claims?
The claims could be construed as being directed to the same or a similar invention, and a double
patenting rejection could be raised for the divisional:
i. If the claims would not necessitate a further search:
1. File an amendment after allowance to submit the claims and pay the fee ($400)
for such amendment.
ii. If the claims would necessitate a further search:
19
1. Let the application go abandoned (Section 73(1)(f) of the Patent Act; Section
30(10)(a) of the Patent Rules) for failure to pay the final fee,
2. Pay the reinstatement fee ($200) (Section 73(3) of the Patent Act),
3. Pay the final fee ($400) (Section 32(a) of the Patent Rules and item 5 of
SCHEDULE II), and
4. File a voluntary amendment at the same time to introduce the new claims
(2018)
A PCT application was filed June 1, 2016, claiming priority from a US provisional patent
application filed June 2, 2015. If today is December 12, 2017, would you be able to enter
national phase in:
(a) Canada?
Canada – Yes, can enter national phase within 42 months of the priority date; (to review in view of new rules)
A PCT application was filed June 1, 2016, claiming priority from a US provisional patent
application filed June 2, 2015. If today is December 12, 2017, would you be able to enter
national phase in
US?
Provide reasons to support your answer. No authority or statutory support is required
US – No, more than 30 months from the priority date;
2018
A PCT application was filed June 1, 2016, claiming priority from a US provisional patent
application filed June 2, 2015. If today is December 12, 2017, would you be able to enter
national phase in India?
Provide reasons to support your answer. No authority or statutory support is required
Yes, still within 31 months from the priority date;
2018
A PCT application was filed June 1, 2016, claiming priority from a US provisional patent
application filed June 2, 2015. If today is December 12, 2017, would you be able to enter
national phase in Taiwan?
Provide reasons to support your answer. No authority or statutory support is required
No, Taiwan is not a PCT contracting state.
2018
What is required to add XX as an inventor? Apply the appropriate Section(s)
of the Patent Act and/or Patent Rules
Pursuant to subsection 31(4) of the Patent Act, where an application is filed by one or
more applicants and it subsequently appears that one or more further applicants
(includes an inventor) should have been joined, the further applicant or applicants
may be joined on satisfying the Commissioner that he or they should be so joined,
and that the omission of the further applicant or applicants had been by inadvertence
or mistake and was not for the purpose of delay.
(2018)
What is required to remove XX and XX as inventors? Apply the appropriate Section(s) of the Patent Act and/or Patent Rules.
Pursuant to subsection 31(3) of the Patent Act, where an application is filed by joint
applicants and it subsequently appears that one or more of them has had no part in the
invention, the prosecution of the application may be carried on by the remaining
applicant or applicants on satisfying the Commissioner by affidavit that the remaining
applicant or applicants is or are the sole inventor or inventors.
(2018)
true or false?
Apply the appropriate Section(s) of the Patent Act and/or Patent Rules.
A request for re-examination may only be filed by the patentee, or a competitor of the
owner.
False – 48.1 (1) of the Patent Act. Any person can request re-examination.
(2018)
true or false?
Apply the appropriate Section(s) of the Patent Act and/or Patent Rules.
A re-examination board has to complete the re-examination proceeding within 12 months
once the re-examination board has caused a re-examination to be made of the claim of the patent
in respect of which the request for re-examination was submitted.
True – 48.3 (3) of the Patent Act.
2018
true or false?
Apply the appropriate Section(s) of the Patent Act and/or Patent Rules.
A patentee may submit a reply to the notice of the re-examination board setting out
substantial new questions on the patentability of one or more claims.
True – 48.2 (5) of the Patent Act.
2018
true or false?
Apply the appropriate Section(s) of the Patent Act and/or Patent Rules.
A determination by the re-examination board that the request for re-examination did not
raise a substantial new question affecting patentability of a claim of the patent may not be
appealed to any court.
True – 48.2 (5) of the Patent Act.
2018
You are the Patent Agent for JU CORP in Canada and you inform the CEO that his Canadian
patent application became abandoned last month for failure to pay a maintenance fee. He does
not understand this at all, because he remembers that he personally paid the correct amount to
CIPO well before the fee was due. Explain to him what went wrong and how it can be corrected,
if possible. No authority or statutory support is required.
In Canada, only the authorized representative of JU CORP (usually the Agent) can pay the
maintenance fees for patent applications. The CEO was not the authorized representative. The
application can be reinstated by having the authorized representative pay the reinstatement fee
($200) and pay the missing maintenance fee.
(2018)